Literature DB >> 10733678

Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis.

M Schaller1, C Schackert, H C Korting, E Januschke, B Hube.   

Abstract

Secreted aspartic proteinases (Saps) encoded by 10 genes of Candida albicans are important virulence factors for different types of candidiasis. Distinct SAP genes have previously been shown to contribute to tissue damage in a model of oral candidiasis. In this study a progressive SAP expression in the order SAP1 and SAP2 > SAP8 > SAP6 > SAP3 was observed in an in vitro model of cutaneous candidiasis based on reconstituted human epidermis. Transcripts of SAP1 and SAP2 were detected during initial invasion of the stratum corneum by C. albicans. Deeper, extensive penetration of the corneal layer was accompanied by additional SAP8 mRNA. SAP6 expression occurred concomitantly with germ tube formation and extensive hyphal growth in the strata granulosum, spinosum, and basale. Ultrastructural studies using specific polyclonal antibodies directed against the gene products of SAP1-3 and SAP4-6 revealed predominant expression of Sap1-3. The protective effect of the aspartic proteinase inhibitor pepstatin A during infection of the epidermis and an attenuated virulence phenotype of SAP-deficient mutants suggest that the observed SAP expression correlates with tissue damage in the skin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733678     DOI: 10.1046/j.1523-1747.2000.00935.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  32 in total

1.  In vitro Candida albicans biofilm induced proteinase activity and SAP8 expression correlates with in vivo denture stomatitis severity.

Authors:  Gordon Ramage; Brent Coco; Leighann Sherry; Jeremy Bagg; David F Lappin
Journal:  Mycopathologia       Date:  2012-07       Impact factor: 2.574

2.  Novel Aggregation Properties of Candida albicans Secreted Aspartyl Proteinase Sap6 Mediate Virulence in Oral Candidiasis.

Authors:  Rohitashw Kumar; Darpan Saraswat; Swetha Tati; Mira Edgerton
Journal:  Infect Immun       Date:  2015-07       Impact factor: 3.441

Review 3.  Candida albicans cell wall proteins.

Authors:  W LaJean Chaffin
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

4.  Comparison between Candida albicans agglutinin-like sequence gene expression patterns in human clinical specimens and models of vaginal candidiasis.

Authors:  Georgina Cheng; Karen Wozniak; Matthew A Wallig; Paul L Fidel; Suzanne R Trupin; Lois L Hoyer
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  "In vitro" antifungal activity of protease inhibitors.

Authors:  S Mata-Essayag; S Magaldi; C Hartung de Capriles; L Deibis; G Verde; C Perez
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

6.  Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes.

Authors:  Arianna Tavanti; Giacomo Pardini; Daniele Campa; Paola Davini; Antonella Lupetti; Sonia Senesi
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 7.  Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.

Authors:  Julian R Naglik; Stephen J Challacombe; Bernhard Hube
Journal:  Microbiol Mol Biol Rev       Date:  2003-09       Impact factor: 11.056

Review 8.  Xenobiotic bioconversion in human epidermis models.

Authors:  Audra L Stinchcomb
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200

9.  The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium.

Authors:  Martin Schaller; Matthias Bein; Hans C Korting; Stefan Baur; Gerald Hamm; Michel Monod; Sabine Beinhauer; Bernhard Hube
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Effects of yoga exercise on salivary beta-defensin 2.

Authors:  Nobuhiko Eda; Kazuhiro Shimizu; Satomi Suzuki; Yoko Tanabe; Eunjae Lee; Takao Akama
Journal:  Eur J Appl Physiol       Date:  2013-08-08       Impact factor: 3.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.